Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
International Journal of Biological Sciences|March 16, 2013
atf4 promotes β-catenin expression and osteoblastic differentiation of bone marrow mesenchymal stem cellsShibing Yu, Ke Zhu, Yumei Lai, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 29, 2021
Detecting Fibroblast Activation Proteins in Lymphoma Using 68Ga-FAPI PET/CTXiao Jin, Maomao Wei, Shuailiang Wang, et al.
American Journal of Cancer Research|March 8, 2018
miR-34a increases the sensitivity of colorectal cancer cells to 5-fluorouracil in vitro and in vivoQiyue Zhang, Jingyuan Wang, Na Li, et al.
Endocrinology|January 12, 2008
Parathyroid hormone increases activating transcription factor 4 expression and activity in osteoblasts: requirement for osteocalcin gene expressionShibing Yu, Renny T Franceschi, Min Luo, et al.
The Journal of Biological Chemistry|January 4, 2008
General transcription factor IIA-gamma increases osteoblast-specific osteocalcin gene expression via activating transcription factor 4 and runt-related transcription factor 2Shibing Yu, Yu Jiang, Deborah L Galson, et al.
Aging and Disease|April 3, 2023
Pip5k1c Loss in Chondrocytes Causes Spontaneous Osteoarthritic Lesions in Aged MiceMinghao Qu, Mingjue Chen, Weiyuan Gong, et al.
Journal of Hematology & Oncology|March 21, 2018
The proto-oncogene Mer tyrosine kinase is a novel therapeutic target in mantle cell lymphomaCunzhen Shi, Xiangqun Li, Xiaogan Wang, et al.
Oncology Letters|July 12, 2017
Relapsed anaplastic lymphoma kinase-positive large B-cell lymphoma expressed cluster of differentiation 4 and cytokeratin: An initially misdiagnosed case corrected by immunoglobulin κ locus gene rearrangement detectionYunfei Shi, Xianghong Li, Yuqin Song, et al.
Cancer Medicine|January 9, 2023
Different situations of identifying second primary malignant tumors in lymphoma patients with synchronous solid tumorsHongye Gao, Xiaogan Wang, Yumei Lai, et al.
Journal of Translational Medicine|June 6, 2017
CDK4/6 inhibitor-SHR6390 exerts potent antitumor activity in esophageal squamous cell carcinoma by inhibiting phosphorylated Rb and inducing G1 cell cycle arrestJiayuan Wang, Qingqing Li, Jiajia Yuan, et al.
Pageof 7